ATE202282T1 - Verwendung von glycosaminoglycanen zur herstellung eines arzneimittels zur behandlung des chronischen nierenversagens - Google Patents
Verwendung von glycosaminoglycanen zur herstellung eines arzneimittels zur behandlung des chronischen nierenversagensInfo
- Publication number
- ATE202282T1 ATE202282T1 AT95113868T AT95113868T ATE202282T1 AT E202282 T1 ATE202282 T1 AT E202282T1 AT 95113868 T AT95113868 T AT 95113868T AT 95113868 T AT95113868 T AT 95113868T AT E202282 T1 ATE202282 T1 AT E202282T1
- Authority
- AT
- Austria
- Prior art keywords
- peritoneal
- glycosaminoglycans
- treatment
- sulodexide
- subjected
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Nutrition Science (AREA)
- Virology (AREA)
- Zoology (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITBO940436A IT1274351B (it) | 1994-10-06 | 1994-10-06 | Uso di alcuni glicosaminoglicani nella dialisi peritoneale. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE202282T1 true ATE202282T1 (de) | 2001-07-15 |
Family
ID=11340040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95113868T ATE202282T1 (de) | 1994-10-06 | 1995-09-04 | Verwendung von glycosaminoglycanen zur herstellung eines arzneimittels zur behandlung des chronischen nierenversagens |
Country Status (9)
Country | Link |
---|---|
US (1) | US5686432A (de) |
EP (1) | EP0710483B1 (de) |
AT (1) | ATE202282T1 (de) |
DE (1) | DE69521388T2 (de) |
DK (1) | DK0710483T3 (de) |
ES (1) | ES2157277T3 (de) |
GR (1) | GR3036158T3 (de) |
IT (1) | IT1274351B (de) |
PT (1) | PT710483E (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL127896A0 (en) * | 1998-12-31 | 1999-10-28 | Gail Laster | A novel treatment for preeclampsia and related diseases |
MXPA02000142A (es) * | 1999-06-30 | 2003-07-21 | Hamilton Civic Hospitals Res | Composiciones de heparina que inhiben los factores de coagulacion asociados con el coagulo. |
ITMI991503A1 (it) * | 1999-07-08 | 2001-01-08 | Bidifarm S R L | Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c |
US7259152B2 (en) * | 2000-06-07 | 2007-08-21 | Alfa Wasserman, Inc. | Methods and compositions using sulodexide for the treatment of diabetic nephropathy |
JP2004507562A (ja) * | 2000-09-08 | 2004-03-11 | ハミルトン シビック ホスピタルズ リサーチ ディベロップメント インコーポレイテッド | 抗血栓性組成物 |
US20030008844A1 (en) * | 2001-05-17 | 2003-01-09 | Keryx Biopharmaceuticals, Inc. | Use of sulodexide for the treatment of inflammatory bowel disease |
US20030013680A1 (en) * | 2001-06-12 | 2003-01-16 | Keryx | Methods using glycosaminoglycans for the treatment of nephropathy |
PE20030263A1 (es) * | 2001-07-31 | 2003-04-17 | Novartis Ag | Composicion farmaceutica oftalmica |
US8367731B2 (en) | 2005-05-30 | 2013-02-05 | Fresenius Medical Care Deutschland Gmbh | Peritoneal dialysis fluid |
MX2008008213A (es) | 2005-12-22 | 2008-09-03 | Neurochem Int Ltd | Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias. |
US20070155672A1 (en) * | 2006-01-05 | 2007-07-05 | Markus Voges | Sterilized peritoneal dialysis solutions containing heparin |
CN101883794B (zh) * | 2007-10-01 | 2012-11-07 | 生化学工业株式会社 | 低分子化硫酸软骨素及其用途 |
CN101632686A (zh) * | 2008-04-04 | 2010-01-27 | 马斯特里赫特大学 | 糖胺聚糖用于修复糖萼的用途 |
IT1401253B1 (it) * | 2010-04-23 | 2013-07-18 | Uni Degli Studi Carlo Bo Urbino | Uso del sulodexide per la riduzione delle metalloproteinasi di matrice. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1245907B (it) * | 1991-05-17 | 1994-10-25 | Alfa Wassermann Spa | Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica. |
IT1270846B (it) * | 1993-05-10 | 1997-05-13 | Alfa Wassermann Spa | Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica. |
HU219339B (en) * | 1993-09-30 | 2001-03-28 | Seikagaku Kogyo Co Ltd | Dermatan sulphate with low heparin or heparane sulphate content and pharmaceutical compositions comprising them |
-
1994
- 1994-10-06 IT ITBO940436A patent/IT1274351B/it active IP Right Grant
-
1995
- 1995-09-04 EP EP95113868A patent/EP0710483B1/de not_active Expired - Lifetime
- 1995-09-04 PT PT95113868T patent/PT710483E/pt unknown
- 1995-09-04 DE DE69521388T patent/DE69521388T2/de not_active Expired - Lifetime
- 1995-09-04 AT AT95113868T patent/ATE202282T1/de active
- 1995-09-04 ES ES95113868T patent/ES2157277T3/es not_active Expired - Lifetime
- 1995-09-04 DK DK95113868T patent/DK0710483T3/da active
- 1995-09-19 US US08/530,597 patent/US5686432A/en not_active Expired - Lifetime
-
2001
- 2001-06-29 GR GR20010401009T patent/GR3036158T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5686432A (en) | 1997-11-11 |
DK0710483T3 (da) | 2001-09-03 |
EP0710483B1 (de) | 2001-06-20 |
EP0710483A1 (de) | 1996-05-08 |
ES2157277T3 (es) | 2001-08-16 |
GR3036158T3 (en) | 2001-09-28 |
DE69521388T2 (de) | 2001-10-11 |
ITBO940436A1 (it) | 1996-04-06 |
ITBO940436A0 (it) | 1994-10-06 |
PT710483E (pt) | 2001-09-28 |
DE69521388D1 (de) | 2001-07-26 |
IT1274351B (it) | 1997-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE202282T1 (de) | Verwendung von glycosaminoglycanen zur herstellung eines arzneimittels zur behandlung des chronischen nierenversagens | |
Sigler et al. | Solute transport in continuous hemodialysis: a new treatment for acute renal failure | |
EP0804931A3 (de) | Lösungen für die Peritonealdialyse und deren Verwendung zum Verringern von Schädigungen an mesothelialen Zellen | |
Khan et al. | Hypokalemia in peritoneal dialysis patients | |
Mistry et al. | Kinetic and Clinical Studies of β2Microglobulin in Continuous Ambulatory Peritoneal Dialysis: Influence of Renal and Enhanced Peritoneal Clearances Using Glucose Polymer | |
von Lilien et al. | Five years' experience with continuous ambulatory or continuous cycling peritoneal dialysis in children | |
Lamy et al. | Comparison between on-line high-efficiency hemodiafiltration and conventional high-flux hemodialysis for polyclonal free light chain removal | |
Bellomo et al. | Management of acute renal failure in the critically ill with continuous venovenous hemodiafiltration | |
Schmaldienst et al. | Angiogenin: a novel inhibitor of neutrophil lactoferrin release during extracorporeal circulation | |
Samtleben et al. | Membrane plasma exchange: principles and application techniques | |
Kaplan | Continuous arteriovenous hemofiltration and related therapies | |
Brown et al. | Peritoneal clearance of theophylline | |
Davies et al. | Clearance studies in patients with acute renal failure treated by continuous arteriovenous haemodialysis | |
Stefanidis et al. | Influence of coagulation parameters on filter running time during continuous venovenous hemofiltration | |
Gotloib et al. | Hemofiltration in severe septic adult respiratory distress syndrome associated with varicella | |
Paton et al. | Cimetidine disposition in patients on continuous ambulatory peritoneal dialysis | |
Spaia et al. | Variability of peritoneal protein loss in diabetic and nondiabetic patients on continuous ambulatory peritoneal dialysis | |
Von Herrath et al. | Good biocompatibility of the polyamide hemofilter | |
Aberger et al. | Differences in drug removal between standard high-flux and medium cut-off dialyzers in a case of severe vancomycin toxicity | |
JEONG et al. | Effect of Erythropoietin on Dialyzer Reuse, Dialysis Efficacy and Other Clinical Parameters | |
Mehta | New developments in continuous arteriovenous hemofiltration/dialysis | |
Comty et al. | Dialytic therapy in the management of chronic renal failure | |
Horton et al. | Continuous arteriovenous hemofiltration: An alternative to hemodialysis | |
Zobel et al. | Continuous arteriovenous renal replacement therapy | |
Quellhorst et al. | Hemofiltration—Technique and clinical application |